![Susan Franks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Franks
Plus aucun poste en cours
Profil
Susan Franks, former Vice President- Global Regulatory Affairs at Teva Pharmaceuticals USA, Inc., and Senior Vice President & Head-Regulatory Affairs at Braeburn, Inc., has also served as Senior Vice President & Head-Regulatory Affairs at Eliem Therapeutics, Inc. from 2022 to 2023.
She holds an undergraduate degree from Clarkson University and a graduate degree from Lehigh University.
Anciens postes connus de Susan Franks
| Sociétés | Poste | Fin |
|---|---|---|
| CLIMB BIO, INC. | Conseiller Juridique Général | 01/04/2023 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Conseiller Juridique Général | - |
| BRAEBURN INC. | Conseiller Juridique Général | - |
Formation de Susan Franks
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Clarkson University
 Clarkson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Braeburn, Inc.
 Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical products for opioid use disorder | Commercial Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
